221 related articles for article (PubMed ID: 20966402)
1. Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22.
Bonaca MP; Morrow DA; Braunwald E; Cannon CP; Jiang S; Breher S; Sabatine MS; Kempf T; Wallentin L; Wollert KC
Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):203-10. PubMed ID: 20966402
[TBL] [Abstract][Full Text] [Related]
2. Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome.
Cavusoglu E; Marmur JD; Hojjati MR; Chopra V; Butala M; Subnani R; Huda MS; Yanamadala S; Ruwende C; Eng C; Pinsky DJ
Am J Med; 2011 Aug; 124(8):724-30. PubMed ID: 21787901
[TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
4. Effects of loading dose of atorvastatin before percutaneous coronary intervention on periprocedural myocardial injury.
Yu XL; Zhang HJ; Ren SD; Geng J; Wu TT; Chen WQ; Ji XP; Zhong L; Ge ZM
Coron Artery Dis; 2011 Mar; 22(1):87-91. PubMed ID: 21169815
[TBL] [Abstract][Full Text] [Related]
5. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.
Eggers KM; Kempf T; Venge P; Wallentin L; Wollert KC; Lindahl B
Am Heart J; 2010 Jul; 160(1):88-94. PubMed ID: 20598977
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
[TBL] [Abstract][Full Text] [Related]
7. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
[TBL] [Abstract][Full Text] [Related]
8. Distribution of traditional and novel risk factors and their relation to subsequent cardiovascular events in patients with acute coronary syndromes (from the PROVE IT-TIMI 22 trial).
Acharjee S; Qin J; Murphy SA; McCabe C; Cannon CP
Am J Cardiol; 2010 Mar; 105(5):619-23. PubMed ID: 20185006
[TBL] [Abstract][Full Text] [Related]
9. Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22).
Ray KK; Morrow DA; Shui A; Rifai N; Cannon CP
Am J Cardiol; 2006 Oct; 98(7):861-5. PubMed ID: 16996863
[TBL] [Abstract][Full Text] [Related]
10. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
Jansson AM; Aukrust P; Ueland T; Smith C; Omland T; Hartford M; Caidahl K
Circulation; 2009 Jun; 119(25):3181-8. PubMed ID: 19528340
[TBL] [Abstract][Full Text] [Related]
11. Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
Damman P; Kempf T; Windhausen F; van Straalen JP; Guba-Quint A; Fischer J; Tijssen JG; Wollert KC; de Winter RJ; Hirsch A;
Int J Cardiol; 2014 Mar; 172(2):356-63. PubMed ID: 24502880
[TBL] [Abstract][Full Text] [Related]
12. Relationship of plasma erythropoietin to long-term outcome in acute coronary syndrome.
Szummer K; Lindahl B; Sylvén C; Jernberg T
Int J Cardiol; 2010 Aug; 143(2):165-70. PubMed ID: 19269703
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival after surgery for acute coronary syndromes in relation to perioperative troponin T release and angina class - a prospective study in 200 patients.
Bjessmo S; Svenarud P; Tran PK
Thorac Cardiovasc Surg; 2009 Apr; 57(3):148-52. PubMed ID: 19330751
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.
de Lemos JA; Morrow DA; Bentley JH; Omland T; Sabatine MS; McCabe CH; Hall C; Cannon CP; Braunwald E
N Engl J Med; 2001 Oct; 345(14):1014-21. PubMed ID: 11586953
[TBL] [Abstract][Full Text] [Related]
15. Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events.
Palikhe A; Sinisalo J; Seppänen M; Haario H; Meri S; Valtonen V; Nieminen MS; Lokki ML
Am J Cardiol; 2007 Apr; 99(7):890-5. PubMed ID: 17398178
[TBL] [Abstract][Full Text] [Related]
16. On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study).
Khera AV; Wolfe ML; Cannon CP; Qin J; Rader DJ
Am J Cardiol; 2010 Aug; 106(4):451-6. PubMed ID: 20691300
[TBL] [Abstract][Full Text] [Related]
17. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
Foussas SG; Zairis MN; Lyras AG; Patsourakos NG; Tsirimpis VG; Katsaros K; Beldekos DJ; Handanis SM; Mytas DZ; Karidis KS; Tselioti PG; Prekates AA; Ambrose JA
Am J Cardiol; 2005 Aug; 96(4):533-7. PubMed ID: 16098307
[TBL] [Abstract][Full Text] [Related]
18. Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study).
Schopfer DW; Ku IA; Regan M; Whooley MA
Am Heart J; 2014 Feb; 167(2):186-192.e1. PubMed ID: 24439979
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of B-type natriuretic Peptide in patients with unstable angina pectoris or acute myocardial infarction: prognostic significance and therapeutic implications.
Ahmed W; Zafar S; Alam AY; Ahktar N; Shah MA; Alpert MA
Angiology; 2007; 58(3):269-74. PubMed ID: 17626979
[TBL] [Abstract][Full Text] [Related]
20. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl.
Spencer FA; Goldberg RJ; Gore JM; Fox KA; Avezum A; Agnelli G; Kritharides L; Anderson FA; Goodman SG; FitzGerald G; Allegrone J; Brieger D;
Am J Cardiol; 2007 Sep; 100(6):913-8. PubMed ID: 17826369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
